康宁杰瑞制药-B发盈喜 预计中期利润不少于2000万元

Core Viewpoint - Corning Jereh Pharmaceutical-B (09966) expects to achieve a profit of no less than RMB 20 million for the six months ending June 30, 2025, compared to a loss of approximately RMB 44.9 million in the same period of 2024 [1] Group 1 - The company is transitioning from a loss to a profit during the reporting period [1] - The turnaround is primarily attributed to milestone revenues from three licensing collaborations and sales revenue from commercialized products [1]